Not recruitingISRCTN44468346
Assessment of Augmentation Strategies to Optimize the Therapeutic Response to Mirtazapine in Major Depression
Research studyAges 18+Canada + United States
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Canada · United States
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Organon International Inc. (USA)
- Sponsor type
- Other organization
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United States, Canada
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN44468346
- Official title
Show the full official title
Assessment of Augmentation Strategies to Optimize the Therapeutic Response to Mirtazapine in Major Depression
Recruitment & locations
Not recruitingCanada · United States
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Organon International Inc. (USA).
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Are antidepressants more effective than placebo, when given in combination with mood stabilisers, in preventing mood episodes in people with Bipolarity type I?
Breath-focused mindfulness and compassion training for parent-child dyads